Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) EBITDA (2021 - 2025)

Biote (BTMD) has 3 years of EBITDA data on record, last reported at $5.6 million in Q4 2023.

  • For Q4 2023, EBITDA fell 26.24% year-over-year to $5.6 million; the TTM value through Dec 2023 reached $13.4 million, up 119.26%, while the annual FY2024 figure was $1.0 million, 96.56% down from the prior year.
  • EBITDA reached $5.6 million in Q4 2023 per BTMD's latest filing, down from $7.8 million in the prior quarter.
  • Across five years, EBITDA topped out at $15.6 million in Q4 2021 and bottomed at -$85.3 million in Q2 2022.
  • Average EBITDA over 3 years is -$2.6 million, with a median of $2.8 million recorded in 2021.
  • The widest YoY moves for EBITDA: up 166.67% in 2022, down 852980.0% in 2022.
  • A 3-year view of EBITDA shows it stood at $15.6 million in 2021, then plummeted by 51.28% to $7.6 million in 2022, then decreased by 26.24% to $5.6 million in 2023.
  • Per Business Quant database, its latest 3 readings for EBITDA were $5.6 million in Q4 2023, $7.8 million in Q3 2023, and -$1000.0 in Q2 2023.